All posts
May 4, 2026
Landscape
The MASH Pipeline in 2026: Two Approvals, $8 Billion in M&A, and 16 Phase 3 Trials
Weekly intelligence on clinical trial activity, competitive moves, and pipeline trends. All data sourced from ClinicalTrials.gov.